Positron emission tomography detects evidence of viability in rest technetium-99m sestamibi defects.

[1]  J. Votaw,et al.  Estimation of left ventricular mass and infarct size from nitrogen-13-ammonia PET images based on pathological examination of explanted human hearts. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  V. Dilsizian,et al.  Metabolic evidence of viable myocardium in regions with reduced wall thickness and absent wall thickening in patients with chronic ischemic left ventricular dysfunction. , 1992, Journal of the American College of Cardiology.

[3]  V. Dilsizian,et al.  Thallium-201 and technetium-99m-sestamibi for assessing viable myocardium. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[4]  T. Marwick,et al.  Prediction by postexercise fluoro-18 deoxyglucose positron emission tomography of improvement in exercise capacity after revascularization. , 1992, The American journal of cardiology.

[5]  M. Chiariello,et al.  Identification of viable myocardium in patients with chronic coronary artery disease: comparison of thallium-201 scintigraphy with reinjection and technetium-99m-methoxyisobutyl isonitrile. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  P. Liu.  New Technetium 99m imaging agents: promising windows for myocardial perfusion and viability. , 1992, American journal of cardiac imaging.

[7]  R. Taillefer,et al.  Technetium-99m-sestamibi myocardial perfusion imaging in detection of coronary artery disease: comparison between initial (1-hour) and delayed (3-hour) postexercise images. , 1991, Journal of Nuclear Medicine.

[8]  F. Fazio,et al.  Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  G. Hutchins,et al.  Quantitative evaluation of regional substrate metabolism in the human heart by positron emission tomography. , 1991, Journal of the American College of Cardiology.

[10]  Y. Yonekura,et al.  Metabolic activity in the areas of new fill-in after thallium-201 reinjection: comparison with positron emission tomography using fluorine-18-deoxyglucose. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  S. Hoory,et al.  Effect of coronary occlusion and myocardial viability on myocardial activity of technetium-99m-sestamibi. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  J. Kronauge,et al.  Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium(I) in cultured chick myocardial cells. Mitochondrial and plasma membrane potential dependence. , 1990, Circulation.

[13]  P. McLaughlin,et al.  Are the kinetics of technetium-99m methoxyisobutyl isonitrile affected by cell metabolism and viability? , 1990, Circulation.

[14]  D. Kuhl,et al.  Three-dimensional assessment of myocardial oxidative metabolism: a new approach for regional determination of PET-derived carbon-11-acetate kinetics. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[15]  D. Berman,et al.  Myocardial perfusion imaging with technetium-99m sestamibi SPECT in the evaluation of coronary artery disease. , 1990, The American journal of cardiology.

[16]  A. Sinusas,et al.  Effect of ischemia and postischemic dysfunction on myocardial uptake of technetium-99m-labeled methoxyisobutyl isonitrile and thallium-201. , 1989, Journal of the American College of Cardiology.

[17]  R. Gibbons,et al.  Feasibility of tomographic 99mTc-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging for the assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction. , 1989, Circulation.

[18]  T. Faber,et al.  Quantitative rotational tomography with 201Tl and 99mTc 2-methoxy-isobutyl-isonitrile. A direct comparison in normal individuals and patients with coronary artery disease. , 1989, Circulation.

[19]  M. Verani,et al.  Quantification of myocardial infarction during coronary occlusion and myocardial salvage after reperfusion using cardiac imaging with technetium-99m hexakis 2-methoxyisobutyl isonitrile. , 1988, Journal of the American College of Cardiology.

[20]  M. Phelps,et al.  Relationship between Tl-201, Tc-99m (Sn) pyrophosphate and F-18 2-deoxyglucose uptake in ischemically injured dog myocardium. , 1987, American heart journal.

[21]  M Schwaiger,et al.  Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. , 1986, The New England journal of medicine.

[22]  S L Bacharach,et al.  Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose. , 1991, Circulation.